RBI
NGNE icon

Raiffeisen Bank International’s Neurogene NGNE Stock Holding History

Raiffeisen Bank International’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$830K Buy
43,000
+1,000
+2% +$19.4K 0.01% 404
2025
Q4 		$929K Buy
42,000
+8,000
+24% +$199K 0.01% 360
2025
Q3 		$602K Buy
34,000
+4,000
+13% +$80.3K 0.01% 404
2025
Q2 		$506K Hold
30,000
– – 0.01% 374
2025
Q1 		$436K Buy
30,000
+14,000
+88% +$243K 0.01% 381
2024
Q4 		$356K Buy
+16,000
New +$595K 0.01% 388

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Raiffeisen Bank International's NGNE Position: Q1 2026 in Review

Raiffeisen Bank International increased its Neurogene (NGNE) stake by 2.4% in Q1 2026, buying an estimated $19.4K and bringing the position to 43,000 shares worth $830K. The position accounts for 0.01% of the portfolio, ranked #404.

Raiffeisen Bank International first reported a position in NGNE in Q4 2024 and has held it in 6 quarters since. The position peaked at $929K in Q4 2025. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Raiffeisen Bank International held 43,000 shares of Neurogene worth $830K as of Q1 2026.
  • Raiffeisen Bank International bought 1,000 Neurogene shares in Q1 2026, an estimated $19.4K.
  • Neurogene made up 0.01% of Raiffeisen Bank International's portfolio in Q1 2026, its #404 holding.
  • Raiffeisen Bank International first reported a position in Neurogene in Q4 2024 and has held it in 6 quarters since.
  • Raiffeisen Bank International's Neurogene position peaked at $929K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.